Home    Back

 55. Relapsing polychondritis
 [ 6 clinical trials,    7 drugs(DrugBank: 7 drugs),    10 target genes / 54 target pathways

Searched query = "Relapsing polychondritis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04077736September 10, 201916 September 2019Low-dose Recombinant Human IL-2 for the Treatment of Relapsing PolychondritisA Pilot Study of Low Dose IL-2 in the Treatment of Relapsing PolychondritisRelapsing PolychondritisDrug: Interleukin-2Peking University People's HospitalNot recruiting18 Years70 YearsAll10Phase 2
2JPRN-UMIN0000069502011/12/012 April 2019Effects of additional inhaled tiotropium in relapsing polychondritis with airway involvementRelapsing polychondritisTo record subjective symptoms, pulmonary function, airway diameter and dimension 3 months before, at baseline and 3 months following tiotropiumSt. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal MedicineNot RecruitingNot applicableNot applicableMale and Female20Not selectedJapan
3NCT01272856January 201119 February 2015Study on the Safety of Abatacept in Relapsing PolychondritisAn Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing PolychondritisRelapsing PolychondritisDrug: AbataceptBenaroya Research InstituteBristol-Myers SquibbNot recruiting18 Years80 YearsBoth4Phase 1United States
4JPRN-UMIN0000038692010/07/012 April 2019A clinical study to establish in diagnostic criteria and treatment guideline of relapsing polychondritis.Relapsing polychondritiscorticosteroid+methotrexate
corticosteroid+ciclosporin
St. Marianna University School of MedicineRecruiting20years-oldNot applicableMale and Female30Not selectedJapan
5NCT01104480May 201019 February 2015Tocilizumab for Relapsing PolychondritisEfficacy of Tocilizumab in a Patient With Relapsing PolychondritisRelapsing PolychondritisDrug: TocilizumabMcMaster Children's HospitalNot recruiting12 Years15 YearsMale0Phase 2Canada
No.TrialIDDate_
enrollement
Last_Refreshed_
on
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT01041248January 201019 February 2015Single Patient Study to Treat Relapsing Polychondritis With TocilizumabEfficacy of Tocilizumab in a Patient With Relapsing PolychondritisRelapsing PolychondritisDrug: TocilizumabChildren's Hospital of Eastern OntarioNot recruitingN/AN/AMale1N/ACanada

Back to top